2018-03-13 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 55,646 0.0579% | $150.00 | $8.35M | -35.36% | |
2017-04-19 | Forte Biosciences, Inc. FBRX | director | 20,000 0.0979% | $10.00 | $200,000 | -14.41% | ||
2015-04-21 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 20,000 0.0255% | $130.02 | $2.6M | -18.97% | |
2015-03-19 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 18,106 0.0221% | $120.00 | $2.17M | -13.41% | |
2015-03-17 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 947 0.0003% | $27.28 | $25,834 | -10.71% | |
2014-12-08 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 30,000 0.0241% | $63.55 | $1.91M | -1.11% | |
2014-10-28 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 30,000 0.0238% | $55.45 | $1.66M | +10.79% | |
2014-01-13 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 30,000 0.024% | $50.59 | $1.52M | -22.12% | |
2013-12-20 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 30,000 0.028% | $38.16 | $1.14M | +4.61% | |
2013-10-22 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 30,000 0.0284% | $34.65 | $1.04M | +9.32% | |
2012-02-21 | Alnylam Pharmaceuticals, Inc. ALNY | director | 186,046 0.3613% | $10.75 | $2M | +41.4% | ||
2009-09-10 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 31,200 0.0744% | $22.26 | $694,578 | -24.04% | |
2009-09-09 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 60,000 0.1444% | $22.10 | $1.33M | -22.77% | |
2009-09-04 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 58,800 0.1408% | $22.02 | $1.29M | -22.86% | |
2007-12-04 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 7,192 0.018% | $31.89 | $229,364 | -9.95% | |
2007-12-03 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 11,586 0.0288% | $32.60 | $377,669 | -12.29% | |
2007-11-30 | Sale | Alnylam Pharmaceuticals, Inc. ALNY | director | 37,222 0.0735% | $26.24 | $976,695 | -13.34% | |
2006-01-31 | Alnylam Pharmaceuticals, Inc. ALNY | director | 100,000 0.3221% | $13.00 | $1.3M | +14.14% |